4篇
您的检索式：作者名="Osman Abbasoglu"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Liver transplantation: Yesterday, today and tomorrow显示文摘With the advances in technical skills, management of postoperative complications and improvements in immunosuppressive drugs, liver transplantation is the standard treatment for many patients with chronic liver disease. Today, shortage of donor organs seems to be the major limiting factor for the application of liver transplantation. This review focuses on five issues that are challenging to clinical practice of liver transplantation and relevant to gastroenterologists. These include living donor liver transplantation, recurrent viral hepatitis, non-heart-beating donors, hepatocellular carcinoma, and ABO incompatible liver transplantation. Living donor and non-heart beating donor transplantations were initiated as a solution to increase the donor organ pool and it is expected that there will be an increase in the number of these donors. Recurrent hepatitis C and hepatocellular carcinoma following liver transplantation are among major problems and ongoing research in these diseases may lead to better outcomes in these recipients. | Osman Abbasoglu | 2008 | World Journal of Gastroenterology2008，14，20： | 10 |
| 2 | Role of liver resection in the management of multinodular hepatocellular carcinoma显示文摘Hepatocellular carcinoma(HCC) is the third leadingcause of cancer related deaths worldwide. Various treatment modalities have been applied to HCC depend-ing on the tumor load, functional capacity of the liver and the general condition of the patient. According to Barcelona Clinic Liver Cancer staging strategy and The American Association for the Study of Liver Disease guidelines, surgical resection is not advocated in the tretment of multinodular HCC. Despite this, many recent clinical studies show that, resection can achieve good results in patients with multinodular HCC and 5-year survival rate around 40% can be reached. If resection or transplantation is not performed, these patients are usually managed with palliative procedures such as transarterial chemoembolization, radioembolization and cytotoxic chemotherapy and 5-year survival of this group of patients will be extremely low. Although survival rates are lower and complications may be increased in this group of patients, liver resection can safely be performed in selected patients in experienced centers for the management of multinodular HCC. | Osman Abbasoglu | 2015 | World Journal of Hepatology2015，7，20： | 3 |
| 3 | Sporadic Hereditary Pancreatic Desmoid Tumor: A New Entity?显示文摘 | Tarik Zafer Nursal Osman Abbasoglu | 2003 | Journal of Clinical Gastroenterology2003，，2： | 1 |
| 4 | HEPATIC ARTERY STENOSIS AFTER LIVER TRANSPLANTATION-INCIDENCE, PRESENTATION, TREATMENT, AND LONG TERM OUTCOME显示文摘 | Osman Abbasoglu Marlon F. Levy Mohan S. Vodapally Robert M. Goldstein Bo S. Husberg Thomas A. Gonwa Goran B. Klintmalm | 1997 | Transplantation1997，，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员